Recursion Pharmaceuticals, Inc.
RXRX
Revenue
4.55M
▼-21.54M▼-82.57%
3 Months ChangeAssets
1.45B
▲722.10M▲99.39%
3 Months ChangeLiabilities
413.82M
▲211.88M▲104.92%
3 Months ChangeFree Cash Flow
-108.95M
▼-30.46M▼-38.81%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-10-02
Form 8-K
ID: 0001601830-24-000165
2024-09-03
Form 8-K
ID: 0001601830-24-000148
2024-08-28
Form 8-K
ID: 0001601830-24-000140
2024-08-08
Form 10-Q
ID: 0001601830-24-000115
2024-08-08
Form 8-K
ID: 0001193125-24-196505
2024-08-06
Form 8-K
ID: 0001601830-24-000110
2024-06-27
Form 8-K
ID: 0001601830-24-000091
2024-06-24
Form 8-K
ID: 0001601830-24-000085
2024-06-07
Form 8-K
ID: 0001601830-24-000076
2024-05-24
Form 8-K
ID: 0001601830-24-000065